Tesla
TSLA
Adobe
ADBE
Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
US Stock MarketDetailed Quotes
ELV Elevance Health
- 423.470
- -3.760-0.88%
Close Mar 25 16:00 ET
- 422.980
- -0.490-0.12%
Pre 05:09 ET
96.28BMarket Cap16.49P/E (TTM)
428.950High419.530Low1.31MVolume428.830Open427.230Pre Close555.27MTurnover0.58%Turnover Ratio16.49P/E (Static)227.35MShares560.89552wk High2.33P/B96.07BFloat Cap360.69652wk Low6.52Dividend TTM226.86MShs Float560.895Historical High1.54%Div YieldTTM2.21%Amplitude16.360Historical Low423.955Avg Price1Lot Size
About Elevance Health Company
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.
Company Profile
SymbolELV
Company NameElevance Health
Listing DateOct 30, 2001
Founded1944
CEOMs. Gail Koziara Boudreaux
MarketNYSE
Employees104200
Fiscal Year Ends12-31
Address220 Virginia Avenue
CityIndianapolis
ProvinceIndiana
CountryUnited States of America
Zip Code46204
Phone1-833-401-1577
Company Executives
- Name
- Position
- Salary
- Gail Koziara Boudreaux
- President, Chief Executive Officer and Director
- 21.89M
- Ratnakar V. Lavu
- Executive Vice President and Chief Digital and Information Officer
- --
- Ronald W. Penczek
- Chief Accounting Officer and Controller
- --
- Mark B. Kaye
- Executive Vice President and Chief Financial Officer
- 12.36M
- Charles Morgan Kendrick, Jr
- Executive Vice President and President, Commercial and Specialty Health Benefits
- --
- Felicia F Norwood
- Executive Vice President and President, Government Health Benefits
- 6.48M
- Peter D. Haytaian
- Executive Vice President; President of Carelon and CarelonRx
- 6.98M
- Elizabeth E. Tallett
- Chairman of the Board
- 597.83K
- R. Kerry Clark
- Independent Director
- 371.42K
- Dr. Bahija Jallal, PhD
- Independent Director
- 371.42K
- Robert L. Dixon, Jr
- Independent Director
- 360.34K
- Ryan M. Schneider
- Independent Director
- 347.28K
- Deanna D. Strable-Soethout
- Independent Director
- 365.60K
- Susan Dodson DeVore
- Independent Director
- 345.00K
- Ramiro G. Peru
- Independent Director
- 386.76K
- Antonio Fabio Neri
- Independent Director
- 350.34K
- Lewis Hay, III
- Independent Director
- 362.53K
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.